The calcium-sensing receptor (CaR) is recognized as a member of class 3 of the G-protein coupled receptor superfamily.
The calcium-sensing receptor (CaR) 4 regulates whole body calcium metabolism (1) . Its physiological role in calcium metabolism is underscored by the phenotype of CaR null mice that exhibit severe hyperparathyroidism at birth due to a failure of extracellular Ca 21 -dependent negative feedback on the secretion of parathyroid hormone (PTH) (2) . In addition, well-recognized familial disorders of human calcium metabolism arise from heterozygous mutations of the CaR that either impair receptor function, i.e. familial hypocalciuric hypercalcemia, or inappropriately sensitize the receptor to the extracellular Ca 21 concentration, i.e. autosomal dominant hypocalcemia. Surprisingly, the CaR is widely expressed throughout the human body, including sites in the gastro-intestinal tract and brain that are not clearly related to the control of calcium metabolism. Insights into possible roles of the CaR in these sites comes from the recognition that the CaR is a close relative of class 3 receptors for L-amino acids, including metabotropic glutamate receptors, which specialize in responding to the acidic amino acid Glu and, more recently, class 3 receptors for basic amino acids (3) (Fig. 1) . Based on these considerations, one of us (A.D.C), together with colleagues Steve Quinn and Ed Brown of the Endocrine Hypertension Division of the Brigham and Womens Hospital in Boston, set out to determine whether the CaR might also exhibit amino acid sensitivity and, if so, whether it responded selectively to a discrete subset or to a broader spectrum of amino acids. As a result of this work, we now know that the CaR responds sensitively to aromatic amino acids and more broadly to various subclasses of amino acids (4, 5) . concentration of 2.5 mmol/L in CaR-expressing HEK293 cells, aromatic amino acids were clearly more effective than other amino acids. Thus, the order of effectiveness was aromatics . aliphatics, polars . acidic . basic, branch-chain amino acids (4) . Furthermore, in human parathyroid cells that express the CaR endogenously, the aromatic amino acids L-Phe and L-Trp exhibited higher potencies than other amino acids (5) . At an extracellular Ca 21 concentration of 1.5 mmol/L, for example, the activator concentration inducing 50% efficacy values for L-Phe and L-Trp were 0.12 and 0.14 mmol/L, respectively, lower than for any of the other amino acids tested ( Table 1) .
The CaR is a broad-spectrum L-amino acid sensor Investigation of the effects of the standard 20 genetically encoded amino acids revealed that almost all, with the exception of basic and branch-chain amino acids, were effective activators of the CaR (4). We considered their potencies and fasting plasma concentrations and found many of these amino acids were equivalent activators (5). These amino acids include L-Trp, L-Phe, L-Tyr, L-His, L-Ala, L-Ser, and L-Thr. The results suggest the conclusion that CaR, like other class 3 G-protein coupled receptors (GPCR) including goldfish 5.24 receptors, GPRC6A, and taste receptor T1R1/T1R3 heterodimers, are broad-spectrum amino acid sensors. Furthermore, increasing fold-concentrations of a fasting amino acid mixture also enhanced receptor activity (Fig. 2) . These findings implicate the CaR as a sensor of changes in protein metabolism and also indicate that the CaR may provide a molecular link between protein and calcium metabolism.
Evidence that the CaR amino acid binding site is located in its extracellular domain The CaR extracellular, N-terminal Venus Fly Trap (VFT) domain is related to nutrient sensing, bacterial periplasmic binding proteins (7) , and, in the mammalian genome, to the VFT domains of other class 3 GPCR as well as several ionotropic glutamate receptors [iGlus; (6) ]. However, type-II calcimimetics of the phenylalkylamine class (e.g. cinacalcet), which like amino acids are positive allosteric modulators of the CaR, bind in the receptor's transmembrane domain region (8) . Chimeric receptor analysis was used to resolve whether the amino acid binding site is located in the VFT or transmembrane domains (9) . Consistent with previous analyses, the amino acid L-Phe and the phenylalkylamine type-II calcimimetic NPS R467 both markedly enhanced the sensitivity of the wild-type CaR to extracellular Ca 21 (Fig. 3) . R467 failed, however, to activate a chimeric receptor in which the CaR transmembrane domain was replaced by the rat mGlu-1 transmembrane domain (Fig. 4A) , whereas the effect of L-Phe on these CaR/Glu/Glu chimeric receptors was retained (Fig. 4B) . However, R467, but not L-Phe, activated an N-terminally truncated CaR (not shown) (9) . Thus, unlike phenylalkylamine activators of the CaR, which bind in the transmembrane domain, L-amino acids bind in the CaR VFT domain and mutations of residues in the VFT domain were subsequently used to develop a mutant receptor that retains full sensitivity to Ca 21 ions but is completely insensitive to amino acids (10).
FIGURE 1 Phylogenetic tree analysis of GPCR class 3. The phylogenetic analysis was based on structural relations between the 7-transmembrane domain regions. Broad-spectrum amino acid sensing receptors, including the CaR, GPRC6A, gold-fish 5-24 receptor, and heterodimeric T1R taste receptors, are identified as a distinct clan within class 3. The figure has been redrawn from reference (3). 
TABLE 1 Potencies of various amino acids as activators of endogenous CaR in human parathyroid cells
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Physiological impact of amino acids on cells that are regulated by the CaR The finding that amino acids activate cultured cells that express the CaR heterologously led to the prediction that amino acids are also likely to regulate cells that express the CaR endogenously. To test this hypothesis, we prepared cells from small samples of normal human parathyroid cells and investigated their sensitivity to amino acids in 2 key assays: extracellular Ca 21 -induced Ca 21 mobilization in fura2-loaded cells; extracellular Ca 21 -regulated PTH secretion. We found amino acids had a considerable impact on both assays (5) . First, in fura2-loaded human parathyroid cells, L-Phe and various other CaR-active amino acids, including L-Trp, L-His, and L-Ala, markedly stimulated intracellular Ca 21 mobilization. Second, perifused parathyroid cells exhibited enhanced Ca 21 -dependent suppression of intact PTH secretion in response to all these amino acids. CaR-inactive amino acids, however (including D-isomers of the active amino acids as well as the basic amino acid, L-Arg, and branch chain amino acid, L-Leu), were much less effective. It is interesting that amino acids, which are required for the synthesis of peptide hormones such as PTH, should also suppress its secretion.
High dietary protein intake stimulates urinary calcium excretion in humans (11, 12) and other species including the laboratory rat (13) . Because the CaR is a key regulator of renal tubular calcium reabsorption and, thus, urinary calcium excretion, and amino acids stimulate the CaR, it seems feasible that protein-induced hypercalciuria arises from amino acid-dependent activation of CaR in the kidney and in endocrine cells that contribute to the control of urinary calcium excretion. To test this hypothesis, individual CaR-active amino acids were infused intravenously into female Wistar rats to generate serum levels between 0.5 and 1.0 mmol/L (similar to the change in total serum amino acid concentration that occurs acutely following the ingestion of a protein-rich meal). Interestingly, both L-Phe and L-Ala stimulated urinary calcium excretion (14) .
In addition to sensing changes in the extracellular Ca 21 concentration, the CaR also senses aromatic amino acids, which act as allosteric activators. Although aromatic amino acids are the most potent activators of the CaR, the CaR also responds sensitively to multiple amino acids and, based on their potencies and fasting concentrations, as many as 6-8 different amino acids (15) and infusions of CaR-active amino acids activate renal calcium excretion. It remains to be determined whether amino acids have a physiological role as modulators of CaR activity in the brain (e.g. in the control of myelination by oligodendrocytes) or whether toxic elevations of aromatic amino acids (e.g. in phenylketonuria or tyrosinemia) induce some of their effects by inappropriate activation and/or downregulation of CaR in key sites.
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